Filing Details
- Accession Number:
- 0001181431-11-007348
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-04 09:28:19
- Reporting Period:
- 2011-02-02
- Filing Date:
- 2011-02-04
- Accepted Time:
- 2011-02-04 09:28:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
820096 | Perrigo Co | PRGO | Pharmaceutical Preparations (2834) | 382799573 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1219842 | T John Hendrickson | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Evp Global Operations & Supply | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-02-02 | 1,897 | $0.00 | 61,279 | No | 5 | G | Indirect | By Trust |
Common Stock | Acquisiton | 2011-02-02 | 6,351 | $35.85 | 6,351 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2011-02-02 | 17,222 | $18.18 | 23,573 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2011-02-02 | 10,152 | $14.69 | 33,725 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2011-02-02 | 5,480 | $15.47 | 39,205 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2011-02-02 | 10,767 | $20.50 | 49,972 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2011-02-02 | 3,592 | $30.06 | 53,564 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-02-02 | 33,564 | $72.78 | 20,000 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-02-02 | 20,000 | $73.58 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | G | Indirect | By Trust |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option Right to Buy | Disposition | 2011-02-02 | 6,351 | $0.00 | 6,351 | $35.85 |
Common Stock | Employee Stock Option Right to Buy | Disposition | 2011-02-02 | 17,222 | $0.00 | 17,222 | $18.18 |
Common Stock | Employee Stock Option Right to Buy | Disposition | 2011-02-02 | 10,152 | $0.00 | 10,152 | $14.69 |
Common Stock | Employee Stock Option Right to Buy | Disposition | 2011-02-02 | 5,480 | $0.00 | 5,480 | $15.47 |
Common Stock | Employee Stock Option Right to Buy | Disposition | 2011-02-02 | 10,767 | $0.00 | 10,767 | $20.50 |
Common Stock | Employee Stock Option Right to Buy | Disposition | 2011-02-02 | 3,592 | $0.00 | 3,592 | $30.06 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2018-08-24 | No | 4 | M | Direct | |
0 | 2014-08-16 | No | 4 | M | Direct | |
0 | 2015-09-14 | No | 4 | M | Direct | |
0 | 2016-08-16 | No | 4 | M | Direct | |
0 | 2017-08-30 | No | 4 | M | Direct | |
0 | 2019-08-24 | No | 4 | M | Direct |
Footnotes
- Shares held in John T. Hendrickson Trust, of which the reporting person is the Trustee.
- The price in column 4 is a weighted average. The prices actually received ranged from $72.26 to $73.19. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- The price in column 4 is a weighted average. The prices actually received ranged from $73.33 to $73.79. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- Grant has graded vesting schedule. Date exercisable will vary for each vesting tranche.